A 34-year-old cisgender woman was diagnosed with HIV 1 year ago. Her initial laboratory studies showed a CD4 count of 89 cells/mm3 and a positive Toxoplasma IgG. Because of a history of a rash to trimethoprim-sulfamethoxazole, she received atovaquone as prophylaxis for Pneumocystis pneumonia and Toxoplasma encephalitis. She reports excellent adherence with antiretroviral therapy and the atovaquone.
Which one of the following would be a criterion for discontinuing primary prophylaxis for Toxoplasma encephalitis in an individual taking antiretroviral therapy?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
September 28th, 2023
September 28th, 2023
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5